medigraphic.com
ISSN 1561-302X (Print)

2022, Number 3

<< Back Next >>

Rev cubana med 2022; 61 (3)

Gut microbiota in human health

Bacardi SE

Language: Spanish
References: 17
Page: 1-8
PDF size: 389.11 Kb.


ABSTRACT

Introduction: Microbiota describes a group of microorganisms in a region or period of time that includes bacteria, archaea, protists, fungi, and viruses.
Objectives: To explain the role of the intestinal microbiota in human health.
Methods: A search was carried out in different databases such as NHI, Ebsco and PubMed in Spanish and English, a total of 17 articles were reviewed, most of them are less than 5 years.
Results: Intestinal microbiota is mostly composed of Gram negative, with a cell wall rich in lipopolysaccharides (LPS) that enhances innate immunity by Toll-like receptor (TLR) ligand interaction, triggers the production of proinflammatory cytokines, among others.
Conclusions: Intestinal microbiota functions as an anti-inflammatory signaling agent and regulator of intestinal epithelial permeability.


REFERENCES

  1. Ho J, Nicolucci AC, Virtanen H, Schick A, Meddings J, Reimer RA, et al1. . Effect of prebiotic on microbiota, intestinal permeability, and glycemic control in children with Type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2019[acceso: 21/03/2021];104(10):4427-40.Disponible en: Disponible en: https://academic.oup.com/jcem/article-abstract/104/10/4427/5513497 1.

  2. Castañeda Guillot C. Microbiota intestinal y salud infantil. Rev. Cuban Pediatr. 2018[acceso: 21/03/2021];90(1)94-110. Disponible en:Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312018000100010&lng=es 2. .

  3. Blumberg B. Josué Lederberg (1925-2008). Descubrimientos decisivos en genética bacteriana. Nature. 2008;452(422). DOI:https://doi.org/10.1038/452422a3.

  4. Muñoz Garach A, Díaz Perdigones C, Tinahones FJ. Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr. 2016[acceso: 21/03/2021];63(10):560-8. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S2173509316301209 4.

  5. Imajo K, Yoneda M, Ogawa Y, Wada K, Nakajima A. Microbiota and nonalcoholic steatohepatitis. In Seminars in immunopathology. Springer Berlin Heidelberg. 2014[acceso: 21/03/2021];36(1):115-32. Disponible en:Disponible en:https://link.springer.com/article/10.1007/s00281-013-0404-6 5.

  6. Luche E, Cousin B, Garidou L, Serino M, Waget A, Barreau C, et al6. . Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Molecular metabolism. 2013 [acceso: 21/03/2021];2(3): 281-91. Disponible en:Disponible en:https://www.sciencedirect.com/science/article/pii/S2212877813000598 6.

  7. Boursier J, Mueller O, Barret M. The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota. Hepatology. 2016;63(3). DOI: 10.1002/hep.28356

  8. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clinical & Translational Immunology. 2016;5:e82. DOI: 10.1038/cti.2016.29.

  9. H Verhaar BJ, Prodan A, Nieuwdorp M, Muller M. Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients. 2020;12:2982. DOI: 10.3390/nu12102982

  10. Muñoz Garach A, Díaz Perdigones C, Tinahones FJ. Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr. 2016[acceso: 21/03/2021];63(10):560-8. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S2173509316301209 10.

  11. Boulangé CL, Neves AL, Chilloux J. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Boulangé et al. Genome Medicine. 2016;8:42. DOI 10.1186/s13073-016-0303-2.

  12. Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016;375:2369-79. DOI: 10.1056/NEJMra1600266.

  13. Lin J, Lin S, Vanhoutte PM. Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice. Circulation13. . 2016; 133:2434-46. DOI: 10.1161/CIRCULATIONAHA.115.019645

  14. Arora T, Seyfried F, Docherty NG. Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass. The ISME Journal. 2017[acceso: 21/03/2021];11:2035-46. Disponible en:Disponible en:https://www.nature.com/articles/ismej201770?_scpsug=crawled_1763098_e766e9b0-3d32-11e7-ee92-f01fafd7b417 14.

  15. Baothman OA, Zamzami MA, Taher I. The role of Gut Microbiota in the development of obesity and Diabetes. Baothman Lipids in Health and Disease. 2016[acceso: 21/03/2021];15:108. Disponible en: Disponible en: https://link.springer.com/article/10.1186/s12944-016-0278-4 15.

  16. Groves HT, Higham SL, Moffatt MF, Cox MJ, Tregoning JS. Respiratory viral infection alters the gut Microbiota by inducing inappetence. MBio16. , 2020;11:(1). DOI:10.1128/mBio.03236-19

  17. Van Best N, Rolle Kampczyk U, Schaap FG. Bile acids drive the newborn’s gut microbiota maturation. Nature Communications. 2020;11:3692. DOI: doi.org/10.1038/s41467-020-17183-8




2020     |     www.medigraphic.com